Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01348
|
|||||
| Drug Name |
Benzamil
|
|||||
| Synonyms |
Benzamil; 2898-76-2; UNII-04659UUJ94; N-(N-Benzylamidino)-3,5-diamino-6-chloropyrazine carboxamide; GNF-Pf-192; CHEMBL212579; CHEBI:34558; 04659UUJ94; 3,5-Diamino-6-chloro-N-(imino((phenylmethyl)amino)methyl)pyrazinecarboxamide; 3,5-diamino-N-(N'-benzylcarbamimidoyl)-6-chloropyrazine-2-carboxamide; Pyrazinecarboxamide, 3,5-diamino-6-chloro-N-(imino((phenylmethyl)amino)methyl)-; Spectrum3_001823; Prestwick1_000657; Prestwick3_000657; Prestwick2_000657; Prestwick0_000657; Lopac-B-2417; AC1L33CQ; Lopac0_000211; KBioGR_000300
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Cystic fibrosis [ICD11: CA25] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C13H14ClN7O
|
|||||
| Canonical SMILES |
C1=CC=C(C=C1)CN=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N
|
|||||
| InChI |
InChI=1S/C13H14ClN7O/c14-9-11(16)20-10(15)8(19-9)12(22)21-13(17)18-6-7-4-2-1-3-5-7/h1-5H,6H2,(H4,15,16,20)(H3,17,18,21,22)
|
|||||
| InChIKey |
KXDROGADUISDGY-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 2898-76-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 319.75 | Topological Polar Surface Area | 145 | ||
| Heavy Atom Count | 22 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
1.7
|
|||||
| PubChem CID | ||||||
| PubChem SID |
586340
, 621649
, 4997149
, 11110839
, 11110840
, 11120241
, 11120729
, 11121217
, 11121645
, 11122125
, 11336176
, 11361415
, 11362714
, 11365276
, 11367838
, 11370699
, 11370700
, 11373064
, 11373439
, 11376000
, 11462387
, 11466685
, 11467805
, 11486350
, 11491638
, 15248269
, 26755660
, 26755661
, 44437002
, 47870415
, 47870416
, 48019678
, 48019679
, 48095241
, 48244091
, 48318723
, 48319195
, 48319196
, 48394633
, 49698609
, 50068048
, 50110974
, 50110975
, 50686741
, 53849316
, 57338445
, 85787710
, 85787961
, 90341795
, 92309106
|
|||||
| ChEBI ID |
CHEBI:34558
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis. Eur Respir J. 1999 Sep;14(3):693-6. | |||||
| 2 | Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.